We are live on ! Find out more
MRSN

Mersana Therapeutics

Delisted

MRSN was delisted on the 5th of January, 2026.

130 hedge funds and large institutions have $1.53B invested in Mersana Therapeutics in 2020 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 50 increasing their positions, 23 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

800% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 6

555% more capital invested

Capital invested by funds: $234M → $1.53B (+$1.3B)

491% more call options, than puts

Call options by funds: $7.97M | Put options by funds: $1.35M

125% more funds holding in top 10

Funds holding in top 10: 49 (+5)

117% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 23

59% more funds holding

Funds holding: 82130 (+48)

0.38% more ownership

Funds ownership: 3.53%3.91% (+0.38%)

Holders
130
Holders Change
+48
Holders Change %
+58.54%
% of All Funds
2.67%
Holding in Top 10
9
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+125%
% of All Funds
0.18%
New
54
Increased
50
Reduced
23
Closed
6
Calls
$7.97M
Puts
$1.35M
Net Calls
+$6.62M
Net Calls Change
+$6.68M